Abstract
Journal of Medical VirologyVolume 92, Issue 8 p. 1369-1369 CORRIGENDUMFree Access Corrigendum This article corrects the following: The efficacy and safety of elbasvir/grazoprevir treatment in HCV genotype 1 patients in Taiwan Tzu-Cheng Tsai, Shin-Tarng Deng, Chao-Wei Hsu, Volume 92Issue 2Journal of Medical Virology pages: 219-226 First Published online: October 22, 2019 First published: 12 February 2020 https://doi.org/10.1002/jmv.25687AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat The efficacy and safety of elbasvir/grazoprevir treatment in HCV genotype 1 patients in Taiwan Tzu-Cheng Tsai, Shin-Tarng Deng, Chao-Wei Hsu The article to which this Corrigendum refers was published in Journal of Medical Virology 92(2): 219-226 (https://doi.org/10.1002/jmv.25605). The corrigendum corrects the institute title "Department of Long Term Care, Hsin Sheng College of Medical Care and Management" to "Hsin Sheng Junior College of Medical Care and Management." Authors apologize for the error. REFERENCE Tsai T-C, Deng S-T, Hsu C-W. The efficacy and safety of elbasvir/grazoprevir treatment in HCV genotype 1 patients in Taiwan. J Med Virol. 2020; 92: 219- 226. https://doi.org/10.1002/jmv.25605 Volume92, Issue8August 2020Pages 1369-1369 ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
